SevenBridge Financial Group’s Avanos Medical AVNS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q3
Sell
-125
Closed -$5K 177
2019
Q2
$5K Hold
125
﹤0.01% 514
2019
Q1
$5K Hold
125
﹤0.01% 478
2018
Q4
$6K Hold
125
﹤0.01% 417
2018
Q3
$9K Hold
125
﹤0.01% 423
2018
Q2
$7K Hold
125
﹤0.01% 456
2018
Q1
$6K Hold
125
﹤0.01% 475
2017
Q4
$6K Hold
125
﹤0.01% 478
2017
Q3
$6K Hold
125
﹤0.01% 487
2017
Q2
$5K Buy
125
+113
+942% +$4.27K ﹤0.01% 512
2017
Q1
$0 Sell
12
-31
-72% -$1.21K ﹤0.01% 630
2016
Q4
$1K Hold
43
﹤0.01% 607
2016
Q3
$1K Hold
43
﹤0.01% 592
2016
Q2
$1K Buy
+43
New +$1.32K ﹤0.01% 708

Other funds holding AVNS

SevenBridge Financial Group's AVNS Position: Q3 2019 in Review

SevenBridge Financial Group sold out of Avanos Medical (AVNS) in Q3 2019, closing a stake of 125 shares — an estimated $5K sold.

SevenBridge Financial Group first reported a position in AVNS in Q2 2016 and held it in 13 quarters. The position peaked at $9K in Q3 2018. 290 funds tracked by Wall St. Rank hold AVNS as of Q3 2019.

  • SevenBridge Financial Group reported no remaining Avanos Medical position as of Q3 2019 after selling out during the quarter.
  • SevenBridge Financial Group sold 125 Avanos Medical shares in Q3 2019, an estimated $5K.
  • SevenBridge Financial Group first reported a position in Avanos Medical in Q2 2016 and held it in 13 quarters.
  • SevenBridge Financial Group's Avanos Medical position peaked at $9K in Q3 2018.
  • 290 funds tracked by Wall St. Rank held Avanos Medical as of Q3 2019.

Based on SevenBridge Financial Group's 13F filing for Q3 2019, filed 9 Oct 2019.